EluSys Therapeutics, Inc. ("EluSys" or the "Company") is focused on the development and commercialization of the EluSys Heteropolymer System (the "Technology" or "HP System"), a novel platform technology to treat a wide variety of blood-borne infections and autoimmune diseases.
